KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Intangibles (2016 - 2025)

Historic Intangibles for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $51.3 billion.

  • Pfizer's Intangibles fell 1444.0% to $51.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $51.3 billion, marking a year-over-year decrease of 1444.0%. This contributed to the annual value of $55.4 billion for FY2024, which is 1462.1% down from last year.
  • Per Pfizer's latest filing, its Intangibles stood at $51.3 billion for Q3 2025, which was down 1444.0% from $52.7 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Intangibles ranged from a high of $64.9 billion in Q4 2023 and a low of $25.1 billion during Q4 2021
  • In the last 5 years, Pfizer's Intangibles had a median value of $42.0 billion in 2023 and averaged $43.3 billion.
  • As far as peak fluctuations go, Pfizer's Intangibles plummeted by 1883.12% in 2021, and later surged by 7247.28% in 2022.
  • Over the past 5 years, Pfizer's Intangibles (Quarter) stood at $25.1 billion in 2021, then surged by 72.47% to $43.4 billion in 2022, then soared by 49.64% to $64.9 billion in 2023, then fell by 14.62% to $55.4 billion in 2024, then decreased by 7.38% to $51.3 billion in 2025.
  • Its last three reported values are $51.3 billion in Q3 2025, $52.7 billion for Q2 2025, and $54.0 billion during Q1 2025.